Skip to content

Language Processing and TMS

Probing Language Processes Using Transcranial Magnetic Stimulation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05425615
Enrollment
135
Registered
2022-06-21
Start date
2024-06-05
Completion date
2032-06-01
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aphasia, Language, Stroke

Keywords

TMS, Transcranial Magnetic Stimulation, Aphasia, Semantic processing, Phonological processing

Brief summary

This study will examine the effect of TMS on people with stroke and aphasia as well as healthy individuals.

Detailed description

To examine the brain's structure and specific language function and interactive relationships, investigators will implement repetitive or rapid TMS protocols in an active (or sham)-controlled, within-subject, randomized studies. Aims will evaluate the effects of short-term changes on each of the semantic or phonological language process of interest in isolation and changes in the interaction between language sub-processes and their interaction with other cognitive domains that directly or indirectly affect language functions. The brain targets for TMS application will be informed by existing evidence on (correlational but not causal) associations between language regions and specific language processes from numerous prior neuroimaging (e.g., functional magnetic resonance imaging or fMRI) and neuropsychological studies. Healthy individuals and/or stroke survivors with aphasia will be recruited to address these aims.

Interventions

DEVICETranscranial Magnetic Stimulation

Deymed DuoMag XT-100 rTMS

Sponsors

Medical College of Wisconsin
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The participant and outcomes assessor will both be blinded to intervention modalities.

Intervention model description

Multiple studies will be conducted in parallel. But within a study, the interventional assignment will be set to cross-over with 3-4 arms.

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Diagnosed with left hemisphere stroke * Consent date \>= 1 month after stroke onset * Right-handed * Fluent in English * 18 years of age or older

Exclusion criteria

* Severe cognitive, auditory or visual impairments that would preclude cognitive and language testing * Non-decisional per decisionality questionnaire or other clinical assessment * Presence of major untreated or unstable psychiatric disease (e.g. schizophrenia, bipolar disease) * A chronic medical condition that is not treated or is unstable * Presence of 1. cardiac stimulators or pacemakers or intracardiac lines 2. neurostimulators 3. medication infusion device 4. any other implants near the scalp (e.g., cochlear implants) or in the eye 5. metal in the body * Pregnancy * History of skull fractures, or skin diseases * History of ongoing or unmanaged seizures or a family history of epilepsy * Presence of factors that potentially decrease seizure thresholds * On pro-convulsant medications * Untreated Sleep deprivation or insomnia * Ongoing alcoholism or illegal drug abuse (e.g., cocaine or MDMA users) * History of dyslexia or other developmental learning disabilities

Design outcomes

Primary

MeasureTime frameDescription
Reaction time on language task performanceLanguage tasks administered immediately before and/or after TMS administration (same day).Improvement on language task performance as measured by decrease in reaction time.
Accuracy on language task performanceLanguage tasks administered immediately before and/or after TMS administration (same day).Improvement on language task performance as measured by increase in accuracy.

Countries

United States

Contacts

CONTACTSidney Schoenrock
sschoenrock@mcw.edu414-955-7579
PRINCIPAL_INVESTIGATORPriyanka Shah-Basak, PhD

Medical College of Wisconsin

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 14, 2026